These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19087327)

  • 1. Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Akarsubasi M; Rutten GE
    BMC Fam Pract; 2008 Dec; 9():67. PubMed ID: 19087327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Prim Care Diabetes; 2007 Jun; 1(2):69-74. PubMed ID: 18632022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.
    Simmons RK; Carlsen AH; Griffin SJ; Charles M; Christiansen JS; Borch-Johnsen K; Sandbaek A; Lauritzen T
    Diabet Med; 2014 Dec; 31(12):1577-85. PubMed ID: 25185778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study.
    Sandbaek A; Griffin SJ; Rutten G; Davies M; Stolk R; Khunti K; Borch-Johnsen K; Wareham NJ; Lauritzen T
    Diabetologia; 2008 Jul; 51(7):1127-34. PubMed ID: 18443762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
    Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes.
    Schmittdiel JA; Traylor A; Uratsu CS; Mangione CM; Ferrara A; Subramanian U
    J Womens Health (Larchmt); 2009 Dec; 18(12):2065-70. PubMed ID: 20044871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.
    de Vegt F; Dekker JM; Jager A; Hienkens E; Kostense PJ; Stehouwer CD; Nijpels G; Bouter LM; Heine RJ
    JAMA; 2001 Apr; 285(16):2109-13. PubMed ID: 11311100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.
    Lim SC; Tai ES; Tan BY; Chew SK; Tan CE
    Diabetes Care; 2000 Mar; 23(3):278-82. PubMed ID: 10868851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet PG; Gussekloo J; den Elzen WP; Blom JW; de Waal MW; de Ruijter W
    Scand J Prim Health Care; 2015; 33(4):260-8. PubMed ID: 26683286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a participant-driven health education programme in primary care for people with hyperglycaemia detected by screening: 3-year results from the Ready to Act randomized controlled trial (nested within the ADDITION-Denmark study).
    Maindal HT; Carlsen AH; Lauritzen T; Sandbaek A; Simmons RK
    Diabet Med; 2014 Aug; 31(8):976-86. PubMed ID: 24646371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.
    Park KS; Park YJ; Kim SW; Shin CS; Park DJ; Koh JJ; Kim SY; Kim NK; Lee HK
    Korean J Intern Med; 2000 Jan; 15(1):37-41. PubMed ID: 10714090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark.
    Rasmussen SS; Glümer C; Sandbaek A; Lauritzen T; Borch-Johnsen K
    Diabetologia; 2007 Feb; 50(2):293-7. PubMed ID: 17143605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study].
    Henkel E; Köhler C; Temelkova-Kurktschiev T; Hanefeld M
    Dtsch Med Wochenschr; 2002 May; 127(18):953-7. PubMed ID: 11987015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription patterns of lipid lowering agents among older patients in general practice: an analysis from a national database in the Netherlands.
    Kleipool EEF; Nielen MMJ; Korevaar JC; Harskamp RE; Smulders YM; Serné E; Thijs A; Peters MJL; Muller M
    Age Ageing; 2019 Jul; 48(4):577-582. PubMed ID: 31074492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.